These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 20371679

  • 1. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C, Fermo E, Corti S, Molteni M, Faricciotti A, Cortelezzi A, Lambertenghi Deliliers G, Beran M, Onida F.
    Clin Cancer Res; 2010 Apr 15; 16(8):2246-56. PubMed ID: 20371679
    [Abstract] [Full Text] [Related]

  • 2. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A.
    Am J Clin Pathol; 2006 Nov 15; 126(5):789-97. PubMed ID: 17050076
    [Abstract] [Full Text] [Related]

  • 3. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F, Beran M.
    Curr Hematol Rep; 2004 May 15; 3(3):218-26. PubMed ID: 15087071
    [Abstract] [Full Text] [Related]

  • 4. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
    Pich A, Riera L, Sismondi F, Godio L, Davico Bonino L, Marmont F, Francia di Celle P.
    J Clin Pathol; 2009 Sep 15; 62(9):798-801. PubMed ID: 19734476
    [Abstract] [Full Text] [Related]

  • 5. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.
    Cervera N, Itzykson R, Coppin E, Prebet T, Murati A, Legall S, Vey N, Solary E, Birnbaum D, Gelsi-Boyer V.
    Am J Hematol; 2014 Jun 15; 89(6):604-9. PubMed ID: 24595958
    [Abstract] [Full Text] [Related]

  • 6. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
    Gur HD, Loghavi S, Garcia-Manero G, Routbort M, Kanagal-Shamanna R, Quesada A, Khogeer H, Pierce S, Medeiros LJ, Kantarjian H, Khoury JD.
    Am J Surg Pathol; 2018 Jun 15; 42(6):799-806. PubMed ID: 29596070
    [Abstract] [Full Text] [Related]

  • 7. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia--distinct subgroups or two stages of the same disease?
    Voglová J, Chrobák L, Neuwirtová R, Malasková V, Straka L.
    Leuk Res; 2001 Jun 15; 25(6):493-9. PubMed ID: 11337023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.
    Gelsi-Boyer V, Trouplin V, Adélaïde J, Aceto N, Remy V, Pinson S, Houdayer C, Arnoulet C, Sainty D, Bentires-Alj M, Olschwang S, Vey N, Mozziconacci MJ, Birnbaum D, Chaffanet M.
    BMC Cancer; 2008 Oct 16; 8():299. PubMed ID: 18925961
    [Abstract] [Full Text] [Related]

  • 10. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2010 Nov 16; 151(4):365-75. PubMed ID: 20880116
    [Abstract] [Full Text] [Related]

  • 11. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C, Huh HJ, Mun YC, Seong CM, Chung WS, Huh J.
    Int J Lab Hematol; 2015 Apr 16; 37(2):181-9. PubMed ID: 24845343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Daver N, Strati P, Jabbour E, Kadia T, Luthra R, Wang S, Patel K, Ravandi F, Cortes J, Qin Dong X, Kantarjian H, Garcia-Manero G.
    Am J Hematol; 2013 Jan 16; 88(1):56-9. PubMed ID: 23115106
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
    Kohlmann A, Grossmann V, Klein HU, Schindela S, Weiss T, Kazak B, Dicker F, Schnittger S, Dugas M, Kern W, Haferlach C, Haferlach T.
    J Clin Oncol; 2010 Aug 20; 28(24):3858-65. PubMed ID: 20644105
    [Abstract] [Full Text] [Related]

  • 16. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y, Harada H.
    Rinsho Ketsueki; 2016 Feb 20; 57(2):147-55. PubMed ID: 26935632
    [Abstract] [Full Text] [Related]

  • 17. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
    Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186
    [Abstract] [Full Text] [Related]

  • 18. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
    Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P, Ali H, Otoukesh S, Amanam I, Artz A, Ally F, Telatar M, Nakamura R, Marcucci G, Afkhami M.
    Int J Mol Sci; 2024 Sep 23; 25(18):. PubMed ID: 39337700
    [Abstract] [Full Text] [Related]

  • 19. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC, Shih LY, Liang ST, Huang YJ, Kuo MC, Huang CF, Shih YS, Lin TH, Chiu MC, Liang DC.
    Clin Cancer Res; 2015 Aug 01; 21(15):3541-51. PubMed ID: 25840971
    [Abstract] [Full Text] [Related]

  • 20. Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.
    Nösslinger T, Reisner R, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.
    Leuk Res; 2001 Sep 01; 25(9):741-7. PubMed ID: 11489467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.